{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:24:23Z","timestamp":1794579863393,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RO1 NS111767"],"award-info":[{"award-number":["RO1 NS111767"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"PhRMA Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.brainres.2026.150560","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:57:51Z","timestamp":1790006271000},"page":"150560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neuroprotective effects of novel EAAT2 allosteric modulators in excitotoxic and ischemic injury models"],"prefix":"10.1016","volume":"1893","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7813-7304","authenticated-orcid":false,"given":"Katelyn L.","family":"Reeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5517-5129","authenticated-orcid":false,"given":"Simran K.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi Narayana","family":"Reddy Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2184-5980","authenticated-orcid":false,"given":"Joseph M.","family":"Salvino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4791-8746","authenticated-orcid":false,"given":"Andr\u00e9ia C.K.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2026.150560_b0005","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1021\/acs.jmedchem.2c00534","article-title":"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure activity In Vivo","volume":"65","author":"Abram","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainres.2026.150560_b0010","doi-asserted-by":"crossref","DOI":"10.1021\/acscentsci.6c00080","article-title":"Second-Generation of Deuterium-Substituted Glutamate Uptake Enhancers exhibit Superior Drug-like Properties in Preclinical Evaluation","author":"Abram","year":"2026","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.brainres.2026.150560_b0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bjp.0706949","article-title":"Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement","volume":"150","author":"Beart","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2026.150560_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00051","article-title":"Ischemia-Triggered Glutamate Excitotoxicity from the Perspective of Glial Cells","volume":"14","author":"Belov Kirdajova","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.brainres.2026.150560_bib281","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22064","article-title":"Structure and allosteric inhibition of excitatory amino acid transporter 1","volume":"544","author":"Canul-Tec","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2026.150560_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuint.2011.10.017","article-title":"Riluzole elevates GLT-1 activity and levels in striatal astrocytes","volume":"60","author":"Carbone","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2026.150560_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2202-13-38","article-title":"Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation","volume":"13","author":"Carbone","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.brainres.2026.150560_b0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuropharm.2005.05.002","article-title":"Down-regulation of the glial glutamate transporter GLT-1 in rat hippocampus and striatum and its modulation by a group III metabotropic glutamate receptor antagonist following transient global forebrain ischemia","volume":"49","author":"Chen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2026.150560_b0040","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1523\/JNEUROSCI.0792-07.2007","article-title":"Neurite Degeneration Induced by Heme Deficiency Mediated via Inhibition of NMDA Receptor-Dependent Extracellular Signal-Regulated Kinase 1\/2 Activation","volume":"27","author":"Chernova","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2026.150560_b0045","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/neu.480230915","article-title":"Excitotoxic cell death","volume":"23","author":"Choi","year":"1992","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.brainres.2026.150560_b0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.STR.0000252091.36912.65","article-title":"Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation","volume":"38","author":"Chu","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2026.150560_b0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10072-013-1585-4","article-title":"Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury","volume":"35","author":"Cui","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainres.2026.150560_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2026.150560_b0065","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1021\/acsmedchemlett.2c00304","article-title":"Design and Characterization of Novel Small Molecule Activators of Excitatory Amino Acid Transporter 2","volume":"13","author":"Das","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.brainres.2026.150560_b0070","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1007\/s12035-024-04644-0","article-title":"EAAT2 Activation Regulates Glutamate Excitotoxicity and Reduces Impulsivity in a Rodent Model of Parkinson's Disease","volume":"62","author":"Das","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2026.150560_b0075","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.1414055112","article-title":"SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx","volume":"112","author":"Douda","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2026.150560_b0080","article-title":"Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice","volume":"e22578","author":"Fachim","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.brainres.2026.150560_b0085","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1021\/acschemneuro.9b00061","article-title":"Novel positive Allosteric Modulators of Glutamate Transport have Neuroprotective Properties in an in Vitro Excitotoxic Model","volume":"10","author":"Falcucci","year":"2019","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.brainres.2026.150560_b0090","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/jnc.13200","article-title":"Current approaches to enhance glutamate transporter function and expression","volume":"134","author":"Fontana","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2026.150560_b0095","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1021\/acs.jmedchem.3c01909","article-title":"Synthesis and Structure-activity Relationships for Glutamate Transporter Allosteric Modulators","volume":"67","author":"Fontana","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainres.2026.150560_b0100","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1021\/acschemneuro.0c00007","article-title":"Elucidation of the Structure and Synthesis of Neuroprotective Low Molecular Mass Components of the Parawixia bistriata Spider Venom","volume":"11","author":"Forster","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.brainres.2026.150560_b0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2007.10.023","article-title":"Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1","volume":"578","author":"Fumagalli","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2026.150560_b0110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ana.27124","article-title":"Enhancement of Glutamate Uptake as Novel Antiseizure Approach: Preclinical Proof of Concept","volume":"97","author":"Kami\u0144ski","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2026.150560_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117026","article-title":"Allosteric modulation of neurotransmission","volume":"239","author":"Kenakin","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2026.150560_b0120","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcp.22609","article-title":"Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics","volume":"226","author":"Kim","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.brainres.2026.150560_b0125","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI66163","article-title":"Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection","volume":"124","author":"Kong","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2026.150560_b0130","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1021\/acschemneuro.7b00308","article-title":"Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2","volume":"9","author":"Kortagere","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.brainres.2026.150560_b0135","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/aps.2014.1","article-title":"Glutamate transporters in brain ischemia: to modulate or not?","volume":"35","author":"Krzyzanowska","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.brainres.2026.150560_b0140","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1523\/JNEUROSCI.15-03-01835.1995","article-title":"Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations","volume":"15","author":"Lehre","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2026.150560_b0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neulet.2006.06.019","article-title":"NMDA receptor mediated dendritic plasticity in cortical cultures after oxygen-glucose deprivation","volume":"407","author":"Lei","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2026.150560_b0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/cn200072h","article-title":"Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats","volume":"3","author":"Leung","year":"2012","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.brainres.2026.150560_b0155","doi-asserted-by":"crossref","DOI":"10.1113\/EP089624","article-title":"Treatment effects of the combination of ceftriaxone and valproic acid on neuronal and behavioral functions in an epilepsy rat model","author":"Li","year":"2021","journal-title":"Experimental Physiology. N\/a."},{"key":"10.1016\/j.brainres.2026.150560_b0160","article-title":"IL-10 Protects Neurites in Oxygen-Glucose-Deprived Cortical Neurons through the PI3K\/Akt Pathway","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2026.150560_b0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuroscience.2007.02.003","article-title":"Neuroprotective potential of ceftriaxone in in vitro models of stroke","volume":"146","author":"Lipski","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2026.150560_b0170","first-page":"99","article-title":"The role of excitotoxicity and metabolic failure in the pathogenesis of neurological disorders","volume":"6","author":"Massieu","year":"1998","journal-title":"Neurobiology (Bp.)"},{"key":"10.1016\/j.brainres.2026.150560_b0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF02253527","article-title":"Glutamate: its role in learning, memory, and the aging brain","volume":"111","author":"McEntee","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2026.150560_b0180","unstructured":"Mortensen, A.C.K., et al., 2024. Glutamate Transporters in Health and Disease. In: Two Sides of the Same Coin - Neurotransmitters in Health and Disease. Vol., K. Fatima-Shad, T. Heinbockel, ed.^eds. IntechOpen, London."},{"key":"10.1016\/j.brainres.2026.150560_b0185","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tips.2020.04.006","article-title":"Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy","volume":"41","author":"Niello","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2026.150560_b0190","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1523\/JNEUROSCI.4518-15.2016","article-title":"Transient Oxygen\/Glucose Deprivation Causes a delayed loss of Mitochondria and increases Spontaneous Calcium Signaling in Astrocytic Processes","volume":"36","author":"O'Donnell","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2026.150560_b0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fncel.2015.00285","article-title":"Assessing effects on dendritic arborization using novel Sholl analyses","volume":"9","author":"O'Neill","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.brainres.2026.150560_b0200","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/360464a0","article-title":"Cloning and expression of a rat brain L-glutamate transporter","volume":"360","author":"Pines","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2026.150560_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177017","article-title":"Positive allosteric modulation of glutamate transporter reduces cocaine-induced locomotion and expression of cocaine conditioned place preference in rats","volume":"984","author":"Reeb","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2026.150560_b0210","article-title":"Structural and Molecular Determinants of Glutamate Transporter Allosteric Modulators","volume":"100122","author":"Reeb","year":"2026","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2026.150560_b0215","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2026.150560_b0220","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0896-6273(94)90038-8","article-title":"Localization of neuronal and glial glutamate transporters","volume":"13","author":"Rothstein","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2026.150560_b0225","first-page":"348","article-title":"Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis","volume":"3","author":"Rothstein","year":"1995","journal-title":"Clin. Neurosci."},{"key":"10.1016\/j.brainres.2026.150560_b0230","first-page":"7","article-title":"Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis","volume":"68","author":"Rothstein","year":"1995","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.brainres.2026.150560_b0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2026.150560_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.03.008","article-title":"Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease","volume":"32","author":"Scott","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2026.150560_b0245","first-page":"387","article-title":"Dendritic organization in the neurons of the visual and motor cortices of the cat","volume":"87","author":"Sholl","year":"1953","journal-title":"J. Anat."},{"key":"10.1016\/j.brainres.2026.150560_b0250","article-title":"Development of radiolabeling 2-oxo-2-(4-phenylpiperazin-1-yl)acetamide derivatives as potential molecular probes for excitatory amino acid transporter 2","volume":"117981","author":"Song","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.brainres.2026.150560_b0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neulet.2009.02.061","article-title":"Riluzole protects against glutamate-induced slowing of neurofilament axonal transport","volume":"454","author":"Stevenson","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2026.150560_b0260","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1471-4159.2003.01553.x","article-title":"The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings","volume":"84","author":"Suchak","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2026.150560_b0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.20140413","article-title":"Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease","volume":"212","author":"Takahashi","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.brainres.2026.150560_b0270","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1097\/HJH.0b013e328313e403","article-title":"The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke","volume":"26","author":"Thone-Reineke","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.brainres.2026.150560_b0275","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/TA.0b013e31825133c0","article-title":"The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury","volume":"73","author":"Wei","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.brainres.2026.150560_b0280","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnins.2019.00236","article-title":"Repurposing of the \u03b2-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: a Review","volume":"13","author":"Yimer","year":"2019","journal-title":"Front. Neurosci."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326004221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326004221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:26:24Z","timestamp":1794576384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899326004221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":57,"alternative-id":["S0006899326004221"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150560","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of novel EAAT2 allosteric modulators in excitotoxic and ischemic injury models","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150560"}}